Membion GmbH has secured a 5 million euro investment from TechVision Fonds and DeepTech & Climate Fonds to support its innovative membrane bioreactor technology for wastewater treatment.

Information on the Target

Membion GmbH, located in Roetgen near Aachen, has secured an investment of approximately 5 million euros led by TechVision Fonds (TVF) in partnership with DeepTech & Climate Fonds (DTCF). The company specializes in developing and manufacturing membrane bioreactor (MBR) modules optimized for wastewater treatment. Membion’s patented technology enables municipal and industrial wastewater treatment plant operators to meet increasingly stringent water quality standards while significantly reducing operational costs. The funding will support Membion in its broad market entry, the establishment of additional production lines, and the development of new product features.

Dr. Klaus Vossenkaul, CEO of Membion, states, "Our customers need to achieve higher water quality but often lack the space to expand their facilities. By upgrading to our Membion MBR modules, the bacterial load in wastewater can be reduced by a factor of 1,000 compared to conventional systems, while requiring 75% less space than standard MBR plate modules. Additionally, our modules utilize a revolutionary aeration method that decreases the energy requirement for filter backwashing by over 90% compared to traditional MBR systems."

Industry Overview in Germany

The wastewater treatment industry in Germany is facing evolving regulatory demands driven by environmental awareness and increasing population density. With growing urban areas, the demand for innovative wastewater solutions is escalating, necessitating investment in advanced technologies like MBR systems.